Brief: PMV Pharmaceuticals Ended Q2 With $339 Mln In Cash, Cash Equivalents, And Marketable Securities
13/08/2021 11:30
Aug 13 (Reuters) - PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS - ENDED Q2 WITH $339.0 MILLION IN
CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES
* PMV PHARMACEUTICALS QTRLY LOSS PER SHARE $0.29
Source text for Eikon: [https://bit.ly/3iJGIPe]
Further company coverage: PMVP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics